Pharmacogenomic strategies for developing customized chemotherapy in non-small cell lung cancer

Author： Sarries Carme   Haura Eric B   Roig Barbara   Taron Miquel   Abad Albert   Scagliotti Giorgio   Rosell Rafael  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.3, Iss.6, 2002-11, pp. : 763-780

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Neoadjuvant Chemotherapy in Non-Small Cell Lung Cancer

By  

Current Medicinal Chemistry, Vol. 9, Iss. 8, 2002-04 ,pp. : 893-898

Bentham Science Publishers

Access to resources Recommend Favorite

Novel combination chemotherapy in the treatment of non-small cell lung cancer

By Sekine I.   Saijo N.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 6, 2000-09 ,pp. : 1131-1161

Informa Healthcare

Access to resources Recommend Favorite

Picoplatin pharmacokinetics and chemotherapy of non-small cell lung cancer

By Hamilton Gerhard   Olszewski Ulrike  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 10, 2013-10 ,pp. : 1381-1390

Informa Healthcare

Access to resources Recommend Favorite

Combination Chemotherapy with Docetaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer

By Schuette W.  

Clinical Drug Investigation, Vol. 21, Iss. 3, 2001-03 ,pp. : 161-168

Adis International

Access to resources Recommend Favorite

Chemotherapy of Non-small Cell Lung Cancer in Elderly Patients

By  

Current Medicinal Chemistry, Vol. 9, Iss. 16, 2002-08 ,pp. : 1487-1495

Bentham Science Publishers

Access to resources Recommend Favorite